Citadel Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-231,696
Closed -$11.8M – 15964
2024
Q4
$11.8M Buy
231,696
+60,939
+36% +$3M ﹤0.01% 2772
2024
Q3
$7.04M Buy
+170,757
New +$8.2M ﹤0.01% 3423
2023
Q4
– Sell
-3,928
Closed -$237K – 15453
2023
Q3
$257K Sell
3,928
-187,326
-98% -$11.8M ﹤0.01% 9447
2023
Q2
$11.1M Sell
191,254
-112,682
-37% -$7.11M ﹤0.01% 2535
2023
Q1
$18.8M Sell
303,936
-465,633
-61% -$27.9M ﹤0.01% 1986
2022
Q4
$48.9M Buy
769,569
+739,462
+2,456% +$53.6M 0.01% 1137
2022
Q3
$2.19M Buy
30,107
+24,507
+438% +$1.82M ﹤0.01% 5422
2022
Q2
$381K Sell
5,600
-71,077
-93% -$5.11M ﹤0.01% 9252
2022
Q1
$6.95M Buy
+76,677
New +$6.28M ﹤0.01% 3563
2021
Q4
– Sell
-32,544
Closed -$2.79M – 14966
2021
Q3
$2.64M Sell
32,544
-957,454
-97% -$80.4M ﹤0.01% 5666
2021
Q2
$92.3M Buy
989,998
+680,072
+219% +$65.9M 0.02% 718
2021
Q1
$33.2M Buy
309,926
+160,086
+107% +$16.6M 0.01% 1422
2020
Q4
$13.1M Buy
149,840
+129,916
+652% +$9.18M ﹤0.01% 2299
2020
Q3
$1.38M Buy
+19,924
New +$1.28M ﹤0.01% 5428

Other funds holding NARI

Citadel Advisors's NARI Position: Q1 2025 in Review

Citadel Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 231,696 shares — an estimated $11.8M sold.

Citadel Advisors first reported a position in NARI in Q3 2020 and held it in 14 quarters. The position peaked at $92.3M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Citadel Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 231,696 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $11.8M.
  • Citadel Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Citadel Advisors's Inari Medical, Inc. Common Stock position peaked at $92.3M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.